Illumina Inc. (NASDAQ: ILMN)
Diagnostics & Research · San Diego, CA, United States · Founded 1998
- Market capitalization: $20.0 billion
- Annual revenue: $4.34 billion
- Net income: $0.85 billion
- Employees: 7,300
- Sector: Healthcare
- Headquarters: San Diego, United States
- Founded: 1998
Source: Statvoo company profile for Illumina Inc.. Browse all 500+ companies
Illumina makes the DNA sequencing machines that power the genomics revolution. The company's technology is used in roughly 90% of all DNA sequencing worldwide u2014 from cancer diagnostics to prenatal testing to agricultural research. Illumina has driven the cost of sequencing a human genome from $3 billion (Human Genome Project) to under $200. The company is headquartered in San Diego.
Instrument sales (sequencing machines) and recurring consumables (reagents, flow cells) follow the classic razor-and-blade model. Consumables generate the majority of revenue and carry higher margins. The company also sells sequencing services and software. Revenue is about $4.5 billion annually. The installed base of over 25,000 sequencing systems worldwide drives consumable demand.
Founded in 1998 in San Diego. Illumina's acquisition of Solexa in 2007 for $600 million gave it the sequencing technology that would dominate the industry. The company attempted to acquire cancer testing company Grail for $7.1 billion but was forced to divest by EU regulators in 2024 u2014 one of the most high-profile antitrust defeats in biotech. CEO Francis deSouza was replaced in 2023 amid the Grail controversy.
| Market Capitalization | $20.0B |
| Annual Revenue | $4.34B |
| Net Income | $0.85B |
| Profit Margin | 20% |
| Revenue per Employee | $594521K |
| Stock Exchange | NASDAQ |
| Ticker Symbol | ILMN |
Financial data is approximate and based on most recent annual filings.
Illumina's technology has reduced the cost of genome sequencing by a factor of 10 million over two decades u2014 faster than Moore's Law. The Grail acquisition and forced divestiture cost Illumina billions and led to a board shakeup driven by activist investor Carl Icahn. Illumina's NovaSeq X system can sequence over 20,000 genomes per year.
Illumina's sequencing monopoly is under threat from Oxford Nanopore and others for the first time u2014 the Grail debacle was a massive self-inflicted wound, and the company needs to refocus on defending its core franchise.
What is Illumina Inc.'s revenue?
Illumina Inc. generates approximately $4.34 billion in annual revenue.
How many employees does Illumina Inc. have?
Illumina Inc. employs approximately 7,300 people worldwide.
What is Illumina Inc.'s market cap?
Illumina Inc. (ILMN) has a market capitalization of approximately $20.0 billion on the NASDAQ.
When was Illumina Inc. founded?
Illumina Inc. was founded in 1998 and is headquartered in San Diego, CA, United States.
Who is the CEO of Illumina Inc.?
Jacob Thaysen is the current CEO of Illumina Inc..
What is Illumina Inc.'s website?
Illumina Inc.'s official website is illumina.com.
| CEO | Jacob Thaysen |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Founded | 1998 |
| HQ | San Diego, CA |
| Country | United States |
| Website | illumina.com |
See traffic, security, and technical data for Illumina Inc.'s website:
📊 illumina.com stats 📋 WHOIS 🌐 DNS 🔒 SSL